Thomas Walle
#131,439
Most Influential Person Now
Researcher
Thomas Walle's AcademicInfluence.com Rankings
Thomas Wallecomputer-science Degrees
Computer Science
#5805
World Rank
#6128
Historical Rank
Machine Learning
#1676
World Rank
#1698
Historical Rank
Artificial Intelligence
#1911
World Rank
#1943
Historical Rank
Database
#2931
World Rank
#3057
Historical Rank
Download Badge
Computer Science
Thomas Walle's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science Stanford University
- Bachelors Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Thomas Walle Influential?
(Suggest an Edit or Addition)Thomas Walle's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS (2004) (1570)
- Bioavailability of resveratrol (2011) (679)
- Absorption and metabolism of flavonoids. (2004) (563)
- What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol (2011) (411)
- Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability (2006) (332)
- Cellular uptake of dietary flavonoid quercetin 4'-beta-glucoside by sodium-dependent glucose transporter SGLT1. (2000) (276)
- Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. (1998) (252)
- Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. (1999) (248)
- Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? (2007) (245)
- Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. (2005) (244)
- Disposition and metabolism of the flavonoid chrysin in normal volunteers. (2001) (238)
- Cellular Uptake and Efflux of the Tea Flavonoid (-)Epicatechin-3-gallate in the Human Intestinal Cell Line Caco-2 (2003) (235)
- Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. (2000) (223)
- Cancer chemopreventive properties of orally bioavailable flavonoids--methylated versus unmethylated flavones. (2007) (204)
- Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. (2000) (193)
- Extensive Binding of the Bioflavonoid Quercetin to Human Plasma Proteins (1998) (189)
- Resveratrol transport and metabolism by human intestinal Caco‐2 cells (2003) (188)
- Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities (1989) (188)
- Carbon dioxide is the major metabolite of quercetin in humans. (2001) (179)
- Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma (2019) (177)
- Transport and Metabolism of the Tea Flavonoid (–)-Epicatechin by the Human Intestinal Cell Line Caco-2 (2001) (176)
- Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid--extensive binding to protein and DNA. (2003) (171)
- Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption. (2007) (154)
- Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. (2002) (152)
- Radiation effects on antitumor immune responses: current perspectives and challenges (2018) (150)
- Stereoselective delivery and actions of beta receptor antagonists. (1988) (146)
- Taxol metabolism and disposition in cancer patients. (1995) (141)
- Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. (1996) (140)
- Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells. (2003) (128)
- Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites. (1972) (127)
- Fate of the Flavonoid Quercetin in Human Cell Lines: Chemical Instability and Metabolism (1999) (124)
- Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells. (1999) (123)
- The predictable relationship between plasma levels and dose during chronic propranolol therapy (1978) (121)
- Quantitative account of propranolol metabolism in urine of normal man. (1985) (119)
- GLC determination of propranolol, other beta-blocking drugs, and metabolites in biological fluids and tissues. (1974) (117)
- Pathway‐selective sex differences in the metabolic clearance of propranolol in human subjects (1989) (113)
- Stereoselective binding of propranolol to human plasma, α1‐acid glycoprotein, and albumin (1983) (110)
- Induction of UDP-Glucuronosyltransferase UGT1A1 by the Flavonoid Chrysin in Caco-2 Cells—Potential Role in Carcinogen Bioinactivation (2001) (108)
- Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. (2002) (105)
- Methylation of Dietary Flavones Increases Their Metabolic Stability and Chemopreventive Effects (2009) (103)
- Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein. (1993) (99)
- Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2. (2000) (95)
- Simultaneous determination of propranolol and 4-hydroxypropranolol in plasma by mass fragmentography. (1975) (91)
- Cytochrome P450 3A-mediated human liver microsomal taxol 6 alpha-hydroxylation. (1994) (88)
- Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements. (2002) (86)
- Quercetin Induces Necrosis and Apoptosis in SCC-9 Oral Cancer Cells (2005) (86)
- 5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. (2005) (85)
- Taxol transport by human intestinal epithelial Caco-2 cells. (1998) (85)
- Quercetin, a potent and specific inhibitor of the human P-form phenosulfotransferase. (1995) (84)
- Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. (1993) (84)
- Biologic determinants of propranolol disposition: Results from 1308 patients in the beta‐blocker heart attack trial * (1985) (83)
- Covalent binding of the flavonoid quercetin to human serum albumin. (2005) (82)
- Methylation protects dietary flavonoids from rapid hepatic metabolism (2006) (81)
- Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. (2021) (78)
- 4‐Hydroxypropranolol and its glucuronide after single and long‐term doses of propranolol (1980) (77)
- Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9. (2002) (77)
- Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. (2005) (77)
- Stereoselective clearance and distribution of intravenous propranolol (1984) (76)
- Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2. (1999) (75)
- Pharmacokinetic parameters obtained with racemates (1986) (73)
- Food effects on propranolol systemic and oral clearance: Support for a blood flow hypothesis (1986) (73)
- Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells (2000) (72)
- Stereoselective ring oxidation of propranolol in man. (1984) (71)
- Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells. (1998) (69)
- Induction of UDP-Glucuronosyl-Transferase by the Flavonoids Chrysin and Quercetin in Caco-2 Cells (2004) (67)
- Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites. (1987) (67)
- Presystemic and systemic glucuronidation of propranolol (1979) (65)
- The beta-D-glucoside and sodium-dependent glucose transporter 1 (SGLT1)-inhibitor phloridzin is transported by both SGLT1 and multidrug resistance-associated proteins 1/2. (2003) (64)
- Increased clearance of propranolol and theophylline by high‐protein compared with high‐carbohydrate diet (1987) (60)
- Flavonoid glycosides inhibit oral cancer cell proliferation — role of cellular uptake and hydrolysis to the aglycones (2005) (60)
- Acetylation of spermidine and spermine by rat liver and kidney chromatin. (1977) (58)
- Cytotoxic effects of the dietary flavones chrysin and apigenin in a normal trout liver cell line. (2008) (57)
- Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. (1996) (57)
- THE DIETARY POLYPHENOL ELLAGIC ACID IS A POTENT INHIBITOR OF hOAT1 (2005) (56)
- Formation of transient covalent protein and DNA adducts by quercetin in cells with and without oxidative enzyme activity. (2005) (56)
- BENZO[A]PYRENE-INDUCED ORAL CARCINOGENESIS AND CHEMOPREVENTION: STUDIES IN BIOENGINEERED HUMAN TISSUE (2006) (56)
- Food‐induced increase in propranolol bioavailability—Relationship to protein and effects on metabolites (1981) (55)
- Propranolol effects on membrane repolarization time in isolated canine Purkinje fibers: threshold tissue content and the influence of exposure time. (1980) (53)
- Bioavailable Flavonoids: Cytochrome P450-Mediated Metabolism of Methoxyflavones (2007) (51)
- Ring-hydroxylated propranolol: synthesis and beta-receptor antagonist and vasodilating activities of the seven isomers. (1981) (51)
- The Effect of the Solvent on the Reactivity of Potassium and Quaternary Ammonium Phenoxides in Nucleophilic Substitution Reactions. Part III. (1966) (50)
- Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. (2005) (50)
- Biological actions of formoterol isomers. (2002) (49)
- Accumulation and metabolism of the anticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analog chrysin in the Atlantic killifish. (2006) (48)
- Propranolol glucuronide cumulation during long‐term propranolol therapy: A proposed storage mechanism for propranolol (1979) (48)
- Stereochemistry of the in vivo disposition and metabolism of propranolol in dog and man using deuterium-labeled pseudoracemates. (1985) (45)
- Stimulation-induced release of propranolol and norepinephrine from adrenergic neurons. (1979) (44)
- Quantitative metabolic fate of propranolol in the dog, rat, and hamster using radiotracer, high performance liquid chromatography, and gas chromatography-mass spectrometry techniques. (1983) (43)
- Correlation of the electrophysiological and antiarrhythmic properties of the N-acetyl metabolite of procainamide with plasma and tissue drug concentrations in the dog. (1976) (43)
- Aromatase inhibition by bioavailable methylated flavones (2007) (43)
- Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps. (1999) (42)
- Stereoselective sulfation of albuterol in humans. Biosynthesis of the sulfate conjugate by HEP G2 cells. (1993) (42)
- Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells. (2000) (41)
- Novel methoxylated flavone inhibitors of cytochrome P450 1B1 in SCC‐9 human oral cancer cells (2007) (39)
- A stereoselective central hypotensive action of atenolol. (1989) (38)
- Propranolol metabolism in normal subjects: Association with sex steroid hormones (1994) (37)
- Exercise-induced increments in plasma levels of propranolol and noradrenaline. (1983) (37)
- Stereoselective binding of the (-)-enantiomer of propranolol to plasma and extravascular binding sites in the dog. (1983) (37)
- New ring-hydroxylated metabolites of propranolol: species differences and stereospecific 7-hydroxylation. (1982) (35)
- Rat liver microsomal metabolism of propranolol: identification of seven metabolites by gas chromatography-mass spectrometry. (1972) (35)
- Electron impact fragmentation studies of beta-blocking drugs and their metabolites by GC-mass spectroscopy. (1972) (35)
- Massive propranolol metabolite retention during maintenance hemodialysis (1980) (35)
- Dexamethasone induction of taxol metabolism in the rat. (1995) (33)
- The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers. (1994) (32)
- 6 alpha-Hydroxytaxol: isolation and identification of the major metabolite of taxol in human liver microsomes. (1994) (32)
- Comparative in vitro cytotoxic effects of taxol and its major human metabolite 6α-hydroxytaxol (1995) (31)
- Taxol metabolism in rat hepatocytes. (1993) (31)
- Improved bacterial expression of the human P form phenolsulfotransferase (PST): applications to drug metabolism (1996) (31)
- Central nervous system effects and metabolic disposition of a glycol metabolite of propranolol. (1974) (31)
- Cytochrome P450 1B1, a novel chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer. (2007) (31)
- Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response. (1983) (31)
- Qualitative and quantitative studies on the disposition of amitriptyline and other tricyclic antidepressant drugs in man as it relates to the management of the overdosed patient. (1973) (31)
- Improving metabolic stability of cancer chemoprotective polyphenols (2007) (30)
- Stereoselective increase in propranolol bioavailability during chronic dosing in the dog. (1983) (30)
- Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol. (1990) (30)
- Quantitative determination of propranolol, propranolol glycol and N-desisopropylpropranolol in brain tissue by electron capture gas chromatography. (1976) (29)
- Hep G2 cell line as a human model for sulphate conjugation of drugs. (1992) (29)
- Isopropylamine, a biologically active deamination product of propranolol in dogs: identification of deuterated and unlabeled isopropylamine by gas chromatography-mass spectrometry. (1972) (29)
- Partial metabolic clearances as determinants of the oral bioavailability of propranolol. (1986) (29)
- Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique. (1979) (28)
- Stereoselective metabolism ofRS-albuterol in humans (1996) (27)
- Identification of the unusual polyamines 3,3'-diaminodipropylamine and N,N'-bis(3-aminoproply)-1,3-propanediamine in the white shrimp Penaeus setiferus. (1977) (27)
- The Influence of Plasma Binding on Absorption/Exsorption in the Caco‐2 Model of Human Intestinal Absorption (1999) (27)
- Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates. (1983) (27)
- Identification of major sulfate conjugates in the metabolism of propranolol in dog and man. (1983) (27)
- Stereoselective sulfate conjugation of 4-hydroxypropranolol and terbutaline by the human liver phenolsulfotransferases. (1992) (27)
- Benzo[a]pyrene-induced cytochrome P450 1A and DNA binding in cultured trout hepatocytes - inhibition by plant polyphenols. (2007) (26)
- Stereoselective uptake of atenolol into storage granules isolated from PC12 cells. (1989) (26)
- Stereoselective sulphate conjugation of fenoterol by human phenolsulphotransferases. (1997) (26)
- alpha-, gamma-, and epsilon-Muurolene, Major Sesquiterpenes of the Wood of Pinus sylvestris L. and of Swedish Sulphate Turpentine. (1966) (26)
- Stereoselective sulfation of terbutaline by the rat liver cytosol: evaluation of experimental approaches. (1989) (26)
- Naphthoxylactic acid after single and long‐term doses of propranolol (1979) (25)
- Stereoselective sulfate conjugation of isoproterenol in humans: comparison of hepatic, intestinal, and platelet activity. (1993) (25)
- Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women. (2003) (25)
- Enantioselective sulfation of beta 2-receptor agonists by the human intestine and the recombinant M-form phenolsulfotransferase. (1998) (25)
- Site‐specific accumulation of the cancer preventive dietary polyphenol ellagic acid in epithelial cells of the aerodigestive tract (2006) (24)
- Silica gel high-performance liquid chromatography for the simultaneous determination of propranolol and 4-hydroxypropranolol enantiomers after chiral derivatization. (1984) (24)
- S‐adenosyl‐l‐methionine: transcellular transport and uptake by Caco‐2 cells and hepatocytes (2005) (24)
- MITI minimum information guidelines for highly multiplexed tissue images (2021) (22)
- Stereoselective secretion of atenolol from PC12 cells. (1988) (22)
- Sulphonation of N-hydroxy-2-acetylaminofluorene by human dehydroepiandrosterone sulphotransferase (2000) (22)
- Effects of centrally administered propranolol on plasma renin activity, plasma norepinephrine and arterial pressure. (1979) (21)
- Electron-capture gas chromatography of barbituric acids and diphenylhydantoin after pentafluorobenzylation. (1975) (21)
- Assays of CYP2C8- and CYP3A4-mediated metabolism of taxol in vivo and in vitro. (1996) (21)
- Separation of the enantiomers of intact sulfate conjugates of adrenergic drugs by high-performance liquid chromatography after chiral derivatization. (1985) (20)
- Negotiating their right to play: Asian-specific cricket teams and leagues in the UK and Norway (2015) (20)
- Stereoselective binding of propranolol to human plasma, alpha 1-acid glycoprotein, and albumin. (1983) (20)
- Acid Hydrolysis of the Monoisopropyl Ethers of Methyl alpha- and beta-D-Glucopyranoside. (1966) (18)
- Quantitative gas chromatographic determination of picogram quantities of amino and alcoholic compounds by electron capture detection. (1971) (18)
- Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8 (2022) (18)
- Stereoselective sulfate conjugation of racemic 4-hydroxypropranolol by human and rat liver cytosol. (1991) (17)
- Radioimmunoassay of propranolol. (1983) (17)
- Human phenolsulfotransferases: chiral substrates and expression in Hep G2 cells (1994) (16)
- Stereoselective sulfate conjugation of 4-hydroxypropranolol in vitro by different species. (1985) (15)
- Completion rate and impact on physician–patient relationship of video consultations in medical oncology: a randomised controlled open-label trial (2020) (15)
- Comparative in vitro cytotoxic effects of taxol and its major human metabolite 6 alpha-hydroxytaxol. (1995) (15)
- 6-Deoxy-6-p-tolylsulphonyl-D-glucopyranosides. (1966) (15)
- Preparative resolution of the enantiomers of the beta-blocking drug atenolol by chiral derivatization and high-performance liquid chromatography. (1988) (14)
- Enantiomeric interaction in the sulfate conjugation of the beta 2-agonist drug albuterol by the human liver. (1992) (13)
- Quantitative gas chromatographic determination of picogram quantities of amino and alcoholic compounds by electron capture detection. I. Preparation and properties of the heptafluorobutyryl derivatives. (1970) (13)
- O-methylated catechol-like metabolites of propranolol in man. (1978) (12)
- Rabbit hepatocytes in primary culture: Preparation, viability and use in studies of propranolol metabolism (1990) (12)
- Extensive and saturable accumulation of paclitaxel by the human platelet (2004) (12)
- Chemical trapping of labile aldehyde intermediates in the metabolism of propranolol and oxprenolol. (1981) (12)
- Myocardial Sensitivity to Isoproterenol Following Abrupt Propranolol Withdrawal in Conscious Dogs (1981) (12)
- Early kinetics of intravenous propranolol. (1982) (12)
- Synthesis of 4'-hydroxypropranolol sulfate, a major non-beta-blocking propranolol metabolite in man. (1985) (12)
- Studies on the contribution of active metabolites to the anticonvulsant effects of propranolol. (1977) (11)
- Stereoselective accumulation of the beta-receptor blocking drug atenolol by human platelets. (1991) (11)
- Rate Studies of the Michaelis-Arbuzov Reaction between Ethyl Iodide and Cyclic Phosphites. (1966) (11)
- Cardiovascular actions of a new metabolite of propranolol: isopropylamine. (1974) (11)
- Stereochemistry of tissue distribution of racemic propranolol in the dog. (1989) (11)
- Stereoselective metabolism of RS-albuterol in humans. (1996) (10)
- Association of in vivo and in vitro propranolol levels in canine Purkinje fibers with antiarrhythmic effects. (1977) (10)
- Isolation, purification, and structure identification of glucuronic acid conjugates of propranolol and alprenolol and their ring-hydroxylated metabolites. (1984) (10)
- Cricket as ‘utopian homeland’ in the Pakistani diasporic imagination (2013) (10)
- Tumor ENPP1(CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer. (2022) (9)
- Quantitative analysis of naphthoxylactic acid, a major metabolite of propranolol in plasma in man. (1979) (9)
- Time course of development of the antihypertensive effect of propranolol. (1983) (9)
- Chronic treatment with propranolol enhances the synthesis of prostaglandins E2 and I2 by the aorta of spontaneously hypertensive rats. (1990) (9)
- RING-HYDROXYLATED PROPRANOLOL: SYNTHESIS AND β-RECEPTOR ANTAGONIST AND VASODILATING ACTIVITIES OF THE SEVEN ISOMERS (1981) (9)
- Quantitative gas chromatographic determination of nanogram levels of desipramine in serum. (1970) (9)
- Acute hypotensive effects of oral and intravenous propranolol: early alterations in peripheral resistance. (1986) (8)
- Induction of propranolol metabolism in the Hep G2 human hepatoma cell line (1992) (7)
- Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog. (1990) (7)
- Making Places of Intimacy—Ethnicity, Friendship, and Masculinities in Oslo (2007) (7)
- Inhibitors of Prostaglandin Synthesis Reverse the Effects of Chronic β‐Receptor Blockade to Attenuate Adrenergic Neurovascular Transmission in Dogs (1988) (7)
- Cardiovascular effects of a 4'-methylthio analog of propranolol. (1981) (7)
- Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy (2022) (7)
- Isolation from urine of 4'-hydroxypropranolol sulfate, a major new propranolol metabolite, by ion-pair extraction. (1984) (7)
- Stereoselective sulfate conjugation of 4-hydroxypropranolol in humans: comparison of platelet and hepatic activity. (1991) (7)
- Thiophene Analogues of Indenes. II. The Synthesis, Tautomerism, and Metalation of the Thiophene Analogues of 2-Methylindene. (1966) (7)
- Propranolol, alprenolol and oxprenolol metabolism in the dog. Identification of N-methylated metabolites. (1981) (6)
- Enthalpy and Activation Energy of the Fructose Mutarotation Determined by Polarimetry. (1966) (6)
- Combined effects of propranolol and ethanol on human psychomotor performance. (1983) (6)
- Anomalous Optical Rotation and Circular Dichroism of N-Thioacylated alpha-Amino Acids and Derivatives in Various Solvents. (1966) (6)
- Resolution of the seven isomeric ring-hydroxylated propranolols as tert.-butyldimethylsilyl derivatives by capillary gas chromatography--mass spectrometry. (1983) (5)
- Studies on the disposition of amitriptyline and other tricyclic antidepressant drugs in man as it relates to the management of the overdosed patient. (1973) (5)
- Stereoselective sulfation of R,S-4'-hydroxypropranolol by canine hepatic cytosol and partially purified phenolsulfotransferases. (1989) (5)
- Synthesis and structure of an enaminic bis(trifluoroacetyl) derivatives of desipramine. (1972) (5)
- The Importance of Stable Isotope Labelled Drugs in Clinical Pharmacology: With Illustrations from Studies on the Disposition of Propranolol and Nortriptyline in Man (1974) (4)
- Gas chromatography of ether glucuronides as methyl-trifluoroacetyl derivatives. (1974) (4)
- Isomeric ring hydroxylated metabolites of propranolol in rats, man and dogs. (1974) (4)
- Formation of catechol-like and monophenolic metabolites of propranolol by the rat liver 9000G supernatant. (1978) (4)
- Human phenol sulfotransferases: chiral substrates and expression in Hep G2 cells. (1994) (4)
- Influence of food on the intravenous and oral dose kinetics of propranolol in the dog (1985) (4)
- Quantitative gas chromatographic determination of picogram quantities of phenols. (1971) (4)
- Gas chromatographic analysis of chloroquine after a unique reaction with chloroformates. (1983) (4)
- Nicotinic-like effects and tissue disposition of isopropylamine. (1982) (3)
- A Novel Route to 1,3-Dioxoles via a General Acid-Catalyzed Isomerization Reaction. (1966) (3)
- Kinetic and clinical observations in cyanotic children on propranolol therapy (1980) (3)
- SYNTHESIS OF 4′-HYDROXYPROPRANOLOL SULFATE, A MAJOR NON-β-BLOCKING PROPRANOLOL METABOLITE IN MAN (1985) (3)
- Electron-capture detection of tertiary aromatic amines after ring trifluoroacetylation (1975) (3)
- Pharmacokinetics and metabolism of a 4'-methylthio derivative of propranolol in the dog. (1989) (3)
- P-246: Total antioxidant capacity, an important factor affecting blood pressure responses to diet? (2002) (3)
- STUDIES ON THE RELEASE OF PROPRANOLOL FROM ADRENERGIC NEURONS (1979) (2)
- Quantitative gas-chromatographic determination of primary amines in submicrogram quantities after condensation with 2,5-hexanedione. (1968) (2)
- Potent inhibition of MAO mediated propranolol metabolism by dimethyl sulfoxide in Hep G2 cells. (1992) (2)
- Targeting CD73 May Improve Immunotherapy Efficacy in Glioblastoma. (2020) (2)
- Enhanced exercise noradrenaline concentrations during propranolol treatment: a limiting factor in cardiac beta-adrenoceptor blockade. (1988) (2)
- Immunoaffinity isolation of the sulfate conjugate of 4'-hydroxypropranolol from plasma. (1993) (2)
- eHealth intervention to manage symptoms for patients with cancer on immunotherapy (SOFIA): a study protocol for a randomised controlled external pilot trial (2021) (2)
- Single cell profiling reveals novel tumor and myeloid subpopulations in small cell lung cancer (2020) (2)
- Quantitative gas chromatography of picogram quantities of amines as 2,4-dinitrophenyl derivatives. (1968) (2)
- The psychopharmacological effects of a new metabolite of propranolol. (1973) (2)
- Specific Ion Detection of Aryloxy Beta Blocking Drugs for Metabolic Fate Determinations-Applications to Alprenolol in Rats and Dogs (1978) (1)
- Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in man. (1990) (1)
- Supervised discovery of interpretable gene programs from single-cell data (2022) (1)
- Feasibility and sociopsychological impact of video consultations in medical oncology - a randomized controlled open label trial (2020) (1)
- Signatures of plasticity and immunosuppression in a single-cell atlas of human small cell lung cancer. (2021) (1)
- Cellular uptake of a radiolabelled analogue of neurotensin in the Caco‐2 cell model (2005) (1)
- Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent but clinically inapparent in cancer patients under immune checkpoint therapy (2021) (1)
- Determination of Optical Isomers of Beta-Blockers (1989) (1)
- Human Nutrition and Metabolism Flavonoid Glucosides Are Hydrolyzed and Thus Activated in the Oral Cavity in Humans 1 , 2 (2004) (1)
- Ketotifen is a Prodrug. Norketotifen is the active metabolite. (2021) (1)
- Potent and specific effects of orally bioavailable methylated flavones on oral cancer cell proliferation (2007) (1)
- Leucovorin as a prodrug. (1993) (1)
- Cellular Uptake and Efflux of the Tea Flavonoid ( )- Epicatechin-3-gallate in the Human Intestinal Cell Line Caco-2 JAYA BHARATHI VAIDYANATHAN and THOMAS WALLE (2003) (0)
- Treatment with combination of all-trans retinoic acid and interferon-gamma regressed human glioblastoma T98G xenografts in nude mice (2008) (0)
- Intestinal transport and oral bioavailability of the cancer preventive flavonoid 5,7‐dimethoxyflavone is greatly increased compared to its unmethylated analog chrysin (2007) (0)
- Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma (2019) (0)
- Pharmacokinetic obtained with racemates (1986) (0)
- Stereoselective uptake of the beta receptor blocking drug atenolol by human platelets (1990) (0)
- Novel bioavailable inhibitors of benzo[a]pyrene‐induced cytochrome P450 1B1 mRNA in human oral epithelial cells (2006) (0)
- Running title : High absorption and metabolic stability of methylated flavonoids (2006) (0)
- The clearance of propranol through cytochrome P-450 mediated side-chain oxidation is associated with circulating testosterone levels in men (1990) (0)
- Induction of taxol metabolism in the rat by dexamethasone (1994) (0)
- Detrimental effects of hydroxylated human dietary flavonoids, especially chrysin, compared to their methoxylated analogues in normal trout liver cells (2007) (0)
- Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy (2022) (0)
- Menns liv i Lahore, Pakistan (2016) (0)
- Cricket and social networks among Norwegian Pakistanis (2004) (0)
- From the margins to the pitch (2017) (0)
- Gas chromatographic determination of calciferol in preparations containing vitamin A. (1966) (0)
- Epigenetic plasticity cooperates with emergent cell-cell interactions to drive neoplastic tissue remodeling in the pancreas (2022) (0)
- Trygve B. Broch: A Performative Feel for the Game. How Meaningful Sports Shape Gender, Bodies, and Social Life. (2020) (0)
- Flavonoids and Oral Cancer (2012) (0)
- Abstract LB116: CXCL8/Interleukin-8 orchestrates radiation-induced immune responses in pancreatic adenocarcinoma (2022) (0)
- Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas Walle?
Thomas Walle is affiliated with the following schools:
